Evidence map›Paper›PMID 31344782›Full record

ArticleMolecules (Basel, Switzerland)2019

The Flow Dependent Adhesion of von Willebrand Factor (VWF)-A1 Functionalized Nanoparticles in an in Vitro Coronary Stenosis Model.

Yathreb Asaad, Mark Epshtein, Andrew Yee, Netanel Korin

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Yathreb AsaadFaculty of Biomedical Engineering, Technion-Israel Institute of Technology, Haifa 32000, Israel.
Mark EpshteinFaculty of Biomedical Engineering, Technion-Israel Institute of Technology, Haifa 32000, Israel.
Andrew YeeDivision of Hematology and Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.
Netanel KorinFaculty of Biomedical Engineering, Technion-Israel Institute of Technology, Haifa 32000, Israel. korin@bm.technion.ac.il.ORCID 0000-0001-7244-889X
Technion – Israel Institute of Technology · ILBaylor College of Medicine · US

Funding

Israel Science Foundation 902/18
6 · The paper itself

Abstract

In arterial thrombosis, von Willebrand factor (VWF) bridges platelets to sites of vascular injury. The adhesive properties of VWF are controlled by its different domains, which may be engineered into ligands for targeting nanoparticles to vascular injuries. Here, we functionalized 200 nm polystyrene nanoparticles with the VWF-A1 domain and studied their spatial adhesion to collagen or collagen-VWF coated, real-sized coronary stenosis models under physiological flow. When VWF-A1 nano-particles (A1-NPs) were perfused through a 75% stenosis model coated with collagen-VWF, the particles preferentially adhered at the post stenotic region relative to the pre-stenosis region while much less adhesion was detected at the stenosis neck (~ 65-fold less). When infused through collagen-coated models or when the A1 coating density of nanoparticles was reduced by 100-fold, the enhanced adhesion at the post-stenotic site was abolished. In a 60% stenosis model, the adhesion of A1-NPs to collagen-VWF-coated models depended on the location examined within the stenosis. Altogether, our results indicate that VWF-A1 NPs exhibit a flow-structure dependent adhesion to VWF and illustrate the important role of studying cardiovascular nano-medicines in settings that closely model the size, geometry, and hemodynamics of pathological environments.

Indexed as

NanoparticlesPlatelet AdhesivenessAnimalsBlood PlateletsCoronary StenosisDisease Models, AnimalHemodynamicsHumansProtein BindingRecombinant Proteinsvon Willebrand FactorRecombinant Proteinsvon Willebrand Factoratherothrombosisdrug deliverynanoparticle adhesionvon Willebrand factor

Identifiers

PMID31344782
PMCPMC6696590
OpenAlexW2964044283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.